OncoSil Medical Ltd (OncoSil) is an Australian medical device company specialising in innovative cancer treatments. They focus on the development and commercialisation of their proprietary radioactive isotope, OncoSil™, a device designed for the treatment of pancreatic and other types of cancers. OncoSil aims to provide a targeted, localised radiation therapy that delivers high doses of radiation directly to tumour sites, potentially improving treatment outcomes and quality of life for patients. Their approach is particularly focused on offering new hope in the fight against difficult-to-treat cancers.